AEROBIOTIX | Hospital Air Disinfection Systems 200 03152022 | Aerobiotix

Promote a Healthy Environment.

The Aerocure 200 is medical-grade air disinfection device proven to eliminate 99.9% of bacteria, spores and 100% of viruses in the air.¹ The AeroCure is an air-handling system that uses germicidal ultraviolet light and mechanical filtration to remove airborne particulate matter and microorganisms to provide an environment of reduced airborne contaminants.

 

• Continuous germicidal air disinfection using ultraviolet (UV)
• High efficiency air recirculation
• Reduction of airborne microbial contamination¹
• Reduction of bacteria, viruses and spores¹
• Small footprint and low noise

 

With technology.

Contact a Consultant

Promote a Healthy Environment.

 

The Aerocure 200 is medical-grade air disinfection device proven to eliminate 99.9% of bacteria, spores and 100% of viruses in the air.¹ The AeroCure is an air-handling system that uses germicidal ultraviolet light and mechanical filtration to remove airborne particulate matter and microorganisms to provide an environment of reduced airborne contaminants.

 

• Continuous germicidal air disinfection using ultraviolet (UV)
• High efficiency air recirculation
• Reduction of airborne microbial contamination¹
• Reduction of bacteria, viruses and spores¹
• Small footprint and low noise

 

With technology.

Contact a Consultant

TACKLING OTHER PATIENT CARE SPACES
MOST SIGNIFICANT CHALLENGES

Airborne Bacteria

Allergens

Infectious Aerosols

Airborne Bacteria

Allergens

Infectious Aerosols

SOMETIMES WHAT YOU CAN’T SEE, POSES THE GREATEST RISKS.

Indoor air is two to five times more polluted than outdoor air.² As people move through the space, they’re breathing, talking, coughing, sneezing, and shedding skin cells, which contaminates the air.

 

The Aerocure 200 removes SARS-CoV-2 bioaerosols.³

SOMETIMES WHAT YOU CAN’T SEE, POSES THE GREATEST RISKS.

 

Indoor air is two to five times more polluted than outdoor air.² As people move through the space, they’re breathing, talking, coughing, sneezing, and shedding skin cells, which contaminates the air.

 

The Aerocure 200 removes SARS-CoV-2 bioaerosols.³

THE POWER TO ELIMINATE, NOT JUST COLLECT.

Aerocure 200 complements the work of your HVAC system by quietly, quickly and continuously disinfecting the air in occupied rooms.
Pre-filter Cartridge: Easily replaceable multi-layer pre-filter with MERV 11, activated carbon and copper mesh traps large particulate matter and helps to reduce odors.

 

Ultraviolet (UV) Technology: The Aerocure 200 utilizes a unique patented photolytic chamber with germicidal UV light we call INTRAVIOLET™ to slow, trap, and eliminate pathogens.

 

High Efficiency Particulate Air Filter (HEPA) Filtration: Medical-grade HEPA filtration prevents remaining inactive particles from returning to the air.

Download Specs

THE POWER TO ELIMINATE, NOT JUST COLLECT.

Aerocure 200 complements the work of your HVAC system by quietly, quickly and continuously disinfecting the air in occupied rooms.

 

 

Pre-filter Cartridge: Easily replaceable multi-layer pre-filter with MERV 11, activated carbon and copper mesh traps large particulate matter and helps to reduce odors.

 

Ultraviolet (UV) Technology: The Aerocure 200 utilizes a unique patented photolytic chamber with germicidal UV light we call INTRAVIOLET™ to slow, trap, and eliminate pathogens.

 

High Efficiency Particulate Air Filter (HEPA) Filtration: Medical-grade HEPA filtration prevents remaining inactive particles from returning to the air.

Download Specs

MAXIMUM DOSE

Aerobiotix’s lntraViolet™ Core delivers an optimal UV dose that provides the highest level of pathogen inactivation.

Germicidal Lamps

High output UV-C provides a 254 nm wavelength that inactivates pathogen DNA making it nonviable.

UNIQUE Quartz Cylinders

Thousands of cylinders slow and suspend contaminants which increases dwell time and exposure to UV.

UV CHAMBER

UV is constrained within the unit, protecting staff and patients from exposure.

MAXIMUM DOSE

Aerobiotix’s lntraViolet™ Core delivers an optimal UV dose that provides the highest level of pathogen inactivation.

Germicidal Lamps

High output UV-C provides a 254 nm wavelength that inactivates pathogen DNA making it nonviable.

UNIQUE Quartz Cylinders

Thousands of cylinders slow and suspend contaminants which increases dwell time and exposure to UV.

UV CHAMBER

UV is constrained within the unit, protecting staff and patients from exposure.

BREATHE A LITTLE EASIER

The Aerocure 200 continuously removes airborne particulate matter and microorganisms to provide an environment of reduced airborne contaminants.

It’s 99% effective at reducing airborne tuberculosis.⁴

BREATHE A LITTLE EASIER

 

The Aerocure 200 continuously removes airborne particulate matter and microorganisms to provide an environment of reduced airborne contaminants.

It’s 99% effective at reducing airborne tuberculosis.⁴

Even the most robust HVAC system cannot control all airflow and completely prevent dissemination of an infectious aerosol or disease transmission by droplets or aerosols.

-ASHRAE, 2020

Use portable HEPA fan/filtration systems to enhance air cleaning (especially in areas frequently inhabited by people with a higher likelihood of having COVID-19 and/or an increased risk of getting COVID-19).

-CDC, 2021

Even the most robust HVAC system cannot control all airflow and completely prevent dissemination of an infectious aerosol or disease transmission by droplets or aerosols.

-ASHRAE, 2020

Use portable HEPA fan/filtration systems to enhance air cleaning (especially in areas frequently inhabited by people with a higher likelihood of having COVID-19 and/or an increased risk of getting COVID-19).

-CDC, 2021

References:
1. Evans, A. The efficiency of microorganism inactivation by the Aerobiotix air cleaner. (Research Triangle Institute, 2013).
2. Why Indoor Air Quality is Important to Schools. United States Environmental Protection Agency. Accessed August 4, 2021. https://www.epa.gov/iaq-schools/why-indoor-air-quality-important-schools.
3. Barnewall, R. E. & Bischoff, W. E. Removal of SARS-CoV-2 bioaerosols using ultraviolet air filtration. Infect Control Hosp Epidemiology 1–2 (2021).
4. Matuka, O. Evaluation of Aerobiotix ILLUVIA 500UV device performance in reducing airborne Mycobacterium tuberculosis (MTB H37Ra) in a laboratory testing facility. (NIOH, South Africa, 2018).

Download GermZone Pro Specs

Download GermZone Pro Specs 📞 +1-888-978-7087

Download AeroCure 200 Specs

Download AeroCure Vac Specs

Download Illuvia®Sense Specs

Download AeroCure 200 Specs 📞 +1-888-978-7087

Download AeroCure Vac Specs 📞 +1-888-978-7087

Download Illuvia®Sense Specs 📞 +1-888-978-7087

JASON-TODD-VP-SALES-AEROBIOTIX

JASON TODD

Sr. Vice President of Global Sales and Marketing

Jason leads our global sales team and brings over 18 years of Medical Device experience to Aerobiotix. Jason has led top performing National and Regional Sales teams, selling disruptive technology in the Cardiovascular space with Getinge, Surgical Robotics at Hansen Medical and most recently in the Biologics space with Axogen. Jason received his Bachelor of Science Degree from the University of Indianapolis.

MELISSA-GIETZEN-VP-GLOBAL-MARKETING-AEROBIOTIX

MELISSA GIETZEN, MBA

Vice President of Global Marketing

Melissa Gietzen, MBA is a highly skilled strategic marketing professional with over 20 years’ experience in the healthcare industry. She has significant expertise in strategic planning, capital budgeting, service improvement projects, and creating strong successful brands in the orthopedic, cardiac & ophthalmology markets. Melissa holds a undergraduate degree in Management and Organization Development and a masters degree in Business Administration.

DAVID KIRSCHMAN, M.D. President and CEO

DAVID KIRSCHMAN, M.D.

President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D. Director Scientific Affairs

GREGORY CARROLL PH.D.

Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE Chief Commercial Officer

TONY EMBREE

Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D. VP of Clinical and Medical Affairs

COURTNEY ADAMS, Ph.D.

VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO Vice President of Engineering

ANTHONY DEFALCO

Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ Vice President of Client Services

NATHAN UTZ

Vice President of Strategic Accounts

Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.

MICHAEL SCHMITZ Chief Financial Officer

MICHAEL SCHMITZ

Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.